Medicare Enrolled
Dr. Stephen Shore, M.D.
Hematology & Oncology · Broomall, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shore?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shore
Dr. Stephen Shore is a hematology & oncology specialist in Broomall, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shore performed 49,072 Medicare services across 1,605 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shore received a total of $6,295 from 57 pharmaceutical and/or device companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shore is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in PA
$6,295 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,072
Medicare services
Top 12% in PA for hematology & oncology
1,605
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,583 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
22,590 | $2 | $21 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
15,810 | $0 | $6 |
| Iron infusion (Monoferric) | 3,600 | $17 | $76 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,912 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,097 | $8 | $30 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
906 | $8 | $19 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
690 | $100 | $224 |
| Anti-nausea injection (Aloxi/palonosetron) | 520 | $1 | $122 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
337 | $149 | $301 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
215 | $12 | $93 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
176 | $24 | $152 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
159 | $1 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
153 | $112 | $686 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
148 | $2 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
145 | $100 | $232 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
119 | $54 | $304 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
96 | $61 | $205 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
66 | $56 | $334 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
61 | $13 | $105 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
59 | $11 | $73 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
57 | $4 | $20 |
| New patient office visit, complex (60-74 min) | 47 | $181 | $432 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
36 | $9 | $37 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
34 | $146 | $412 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
22 | $81 | $251 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
17 | $66 | $157 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
40.6% high complexity
52.1% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,295
Total received (2018-2024)
Avg $899/year across 7 years
Top 28% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
259
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,691 (74.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,323 (21.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$282 (4.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$958
2023
$674
2022
$261
2021
$322
2020
$439
2019
$1,386
2018
$2,255
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SHIELD THERAPEUTICS INC
$151
EMD Serono, Inc.
$143
Novartis Pharmaceuticals Corporation
$118
ABBVIE INC.
$94
Incyte Corporation
$48
Celgene Corporation
$44
AstraZeneca Pharmaceuticals LP
$40
PFIZER INC.
$36
GENZYME CORPORATION
$34
Eisai Inc.
$28
Merck Sharp & Dohme LLC
$27
Exelixis Inc.
$26
Genmab U.S., Inc.
$24
Daiichi Sankyo Inc.
$23
Mirati Therapeutics, Inc.
$22
Janssen Biotech, Inc.
$21
Astellas Pharma US Inc
$21
E.R. Squibb & Sons, L.L.C.
$20
SpringWorks Therapeutics, Inc.
$19
Sumitomo Pharma America, Inc.
$17
Top 3 companies account for 43.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,463
E.R. Squibb & Sons, L.L.C.
$649
Celgene Corporation
$304
Pharmacyclics LLC, An AbbVie Company
$269
Servier Pharmaceuticals LLC
$256
Merck Sharp & Dohme Corporation
$241
EMD Serono, Inc.
$237
PFIZER INC.
$233
Genentech USA, Inc.
$216
AstraZeneca Pharmaceuticals LP
$210
Novartis Pharmaceuticals Corporation
$182
Amgen Inc.
$156
SHIELD THERAPEUTICS INC
$151
Incyte Corporation
$146
ABBVIE INC.
$94
Astellas Pharma US Inc
$78
Daiichi Sankyo Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$68
Kite Pharma, Inc.
$65
Pharmacyclics LLC, an AbbVie Company
$64
GENZYME CORPORATION
$64
Merck Sharp & Dohme LLC
$61
JAZZ PHARMACEUTICALS INC.
$57
Ipsen Biopharmaceuticals, Inc
$56
Gilead Sciences, Inc.
$56
Genmab U.S., Inc.
$53
MEDIVATION FIELD SOLUTIONS LLC
$52
Seattle Genetics, Inc.
$51
Mirati Therapeutics, Inc.
$51
Eisai Inc.
$50
Jazz Pharmaceuticals Inc.
$49
Dendreon Pharmaceuticals LLC
$43
Regeneron Healthcare Solutions, Inc.
$43
EISAI INC.
$36
Stemline Therapeutics Inc.
$32
TESARO, Inc.
$31
Exelixis Inc.
$26
Teva Pharmaceuticals USA, Inc.
$25
ARRAY BIOPHARMA INC
$23
Verastem, Inc.
$22
Janssen Pharmaceuticals, Inc
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
SANOFI-AVENTIS U.S. LLC
$19
SpringWorks Therapeutics, Inc.
$19
GlaxoSmithKline, LLC.
$17
Sumitomo Pharma America, Inc.
$17
AbbVie Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$16
ADC Therapeutics America, Inc.
$16
Tactile Systems Technology Inc
$16
AMAG Pharmaceuticals, Inc.
$14
Advanced Accelerator Applications
$14
Puma Biotechnology, Inc.
$13
Foundation Medicine, Inc.
$12
Aurobindo Pharma USA, Inc.
$11
Spectrum Pharmaceuticals Inc.
$11
Lilly USA, LLC
$11
Top 3 companies account for 38.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · ALUNBRIG · Abraxane · Alecensa · Avastin · BALVERSA · BAVENCIO · BENDEKA · BOSULIF · BRAFTOVI · Bavencio · CABOMETYX · CALQUENCE · CAMZYOS · CARVYKTI · Copiktra · DARZALEX · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · Enhertu · Epkinly · Erleada · FERAHEME · FLEXITOUCH · FOUNDATIONONE · Folotyn · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Nerlynx · Neulasta · Nplate · OGSIVEO · OPDIVO · ORGOVYX · PEMAZYRE · PLUVICTO · PROVENGE · Padcev · Phesgo · Pomalyst · REBLOZYL · Revlimid · SANDOSTATIN · SARCLISA · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TECENTRIQ · TIBSOVO · TUKYSA · Tivdak · VENCLEXTA · VERZENIO · VYXEOS · Vectibix · Venclexta · Vyloy · XARELTO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
272
Per 100K population
47.2
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shore is a mixed practice specialist, with above-average Medicare volume (top 12% in PA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shore experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Shore performed 22,590 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shore receive payments from pharmaceutical companies?
Yes. Dr. Shore received a total of $6,295 from 57 companies across 259 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shore's costs compare to other hematology & oncology specialists in Broomall?
Dr. Shore's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Broomall
Browse hematology & oncology specialists in Broomall ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in PA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in PA
Which PA hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology